How CRISPR Works: Unpacking the Science of Cas9 and Gene Modification

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...
Morning Overview on MSN

RNA-guided CRISPR tool turns genes on with dose control

Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that the U.S. Patent and Trademark Office ...
IPWatchdog

PTAB Upholds Priority Win for Broad Institute in CRISPR Patent Case

On remand from the Federal Circuit, the Patent Trial and Appeal Board on Thursday reaffirmed its decision that The Broad ...
Nature

CRISPR makes enhanced cancer-fighting immune cells inside mice

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

DNA shape explains crucial gene-therapy challenges

CRISPR is a powerful DNA-editing tool that has underpinned huge advancements in human health care in the last decade. It is a ...
Medical Xpress

CRISPR gene editing in blood stem cells linked to premature aging effects: Study offers solutions

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using CRISPR-Cas9 in combination with AAV6 vectors can trigger inflammatory and ...
Case Western Reserve University

CRISPR: More than just for gene editing?

Case Western Reserve researcher finds new use for revolutionary gene-splicing tool; electrochemical platform could lead to blood test for HPV, parvo or others The gene-editing tool CRISPR has been ...

Here’s What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds. On February 17, ...
The Caledonian-Record

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that the ...